A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD1.11
- USD1.16
- USD1.10
- USD3.60
- 13.00%
- --
- 472.00k
- 68M
- 0.86
- -50.20%
Stock News
2 hours ago
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc.
Yahoo
3 hours ago
CNBC Daily Open: U.S. markets say 'yes' to cheaper shoes from Vietnam, 'eh' to job losses
CNBC
5 hours ago
Sempra: Key Player In A Vital Industry That's Potentially Undervalued
SeekingAlpha
7 hours ago
ServiceNow: Growth Runway Is Still Long And Bright
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
